KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Debt to Equity (2016 - 2025)

Novartis Ag's Debt to Equity history spans 11 years, with the latest figure at $0.62 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 24.87% to $0.62 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.62, a 24.87% increase, with the full-year FY2025 number at $0.62, up 24.87% from a year prior.
  • Debt to Equity hit $0.62 in Q4 2025 for Novartis Ag, up from $0.5 in the prior quarter.
  • Over the last five years, Debt to Equity for NVS hit a ceiling of $0.62 in Q4 2025 and a floor of $0.41 in Q4 2023.
  • Historically, Debt to Equity has averaged $0.48 across 5 years, with a median of $0.44 in 2022.
  • Biggest five-year swings in Debt to Equity: surged 102.14% in 2021 and later dropped 7.44% in 2023.
  • Tracing NVS's Debt to Equity over 5 years: stood at $0.43 in 2021, then grew by 2.32% to $0.44 in 2022, then fell by 7.44% to $0.41 in 2023, then increased by 22.33% to $0.5 in 2024, then increased by 24.87% to $0.62 in 2025.
  • Business Quant data shows Debt to Equity for NVS at $0.62 in Q4 2025, $0.5 in Q4 2024, and $0.41 in Q4 2023.